Elucidating the Genetic Landscape, Phenotypic Spectrum, and Pathogenic Mechanisms in a Turkish Cohort with Primary

Beyhan Tüysüz1,2, Ahmet Okay Çağlayan3, Büşra Kasap1

  • 1Cerrahpasa Medical Faculty, Department of Pediatric Genetics, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Clinical Genetics
|May 15, 2026
PubMed

Insights

This study identifies genetic causes for primary hereditary microcephaly (MCPH) and syndromic primary microcephaly (PM), finding a 53.1% diagnostic yield. Key differences in affected genes and clinical features were observed between MCPH and syndromic PM groups.

Area of Science:

  • Genetics
  • Neurodevelopmental Disorders
  • Human Molecular Genetics

Background:

  • Primary hereditary microcephaly (MCPH) and syndromic primary microcephaly (PM) are distinct neurodevelopmental conditions.
  • Understanding their genetic basis is crucial for diagnosis and potential therapies.

Purpose of the Study:

  • To determine the genetic diagnostic yield and characterize pathogenic mechanisms and clinical features in MCPH and syndromic PM.
  • To differentiate between MCPH and syndromic PM based on genetic and phenotypic data.

Main Methods:

  • Whole-exome sequencing was performed on 87 patients from 64 families with MCPH or syndromic PM.
  • Genetic variants were analyzed for pathogenicity, and clinical features were correlated with genotypes.

Main Results:

  • A diagnostic yield of 53.1% was achieved, identifying 34 disease-causing variants, 15 of which were novel.
  • MCPH-associated genes were found in 17.2% of families, syndromic PM in 35.9%.
  • Distinct gene pathway associations (mitotic division/DNA repair for MCPH; transcription regulation/cell trafficking for syndromic PM) and clinical phenotypes (intellectual disability severity, behavioral issues, facial gestalt) were observed.

Conclusions:

  • Exome sequencing is effective for diagnosing MCPH and syndromic PM, revealing significant genetic heterogeneity.
  • Distinct genetic and clinical profiles differentiate MCPH from syndromic PM.
  • The study identified KNTC1 as a potential candidate gene, expanding the genetic landscape of these disorders.